Development of cytogenomics for prenatal diagnosis: from chromosomes to single nucleotides: a review

Kelvin Yuen Kwong CHAN; Sandy Leung Kuen AU; Anita Sik Yau KAN

doi:10.12809/hkjgom.19.2.08

Authors

Kelvin Yuen Kwong CHAN
Sandy Leung Kuen AU
Anita Sik Yau KAN

DOI:

https://doi.org/10.12809/hkjgom.19.2.08

Keywords:

Prenatal diagnosis, Whole exome sequencing, Whole genome sequencing

Abstract

Prenatal diagnosis encompasses traditional cytogenetics and molecular-based techniques. In the new era of genomics, challenge to prenatal diagnosis has led to revised diagnostic strategies. In this review, we discuss the application of chromosomal microarray and a new prenatal diagnosis workflow in the public setting in Hong Kong. Using this prenatal diagnosis workflow, up to 40% of fetuses with structural anomalies can be identified with an underlying genetic aetiology, leaving the majority of cases undiagnosed. With the advancement of next generation sequencing, we are able to tackle the challenge of investigating chromosomal changes to single nucleotide variant level. Therefore, we also discuss whole exome sequencing, whole genome sequencing, and long-read sequencing, as well as their limitations and prenatal applications. This DNA-based technology should be evaluated for prenatal clinical application in Hong Kong.

References

Armour CM, Dougan SD, Brock JA, et al. Practice guideline: joint CCMG-SOGC recommendations for the use of chromosomal microarray analysis for prenatal diagnosis and assessment of fetal loss in Canada. J Med Genet 2018;55:215-21.

Committee on Genetics and the Society for Maternal-Fetal Medicine. Committee opinion No.682: microarrays and next-generation sequencing technology: the use of advanced genetic diagnostic tools in obstetrics and gynecology. Obstet Gynecol 2016;128:e262-e268.

Malan V, Lapierre JM, Egloff M, et al. A French approach to test fetuses with ultrasound abnormalities using a customized microarray as first-tier genetic test. Cytogenet Genome Res 2015;147:103-10.

Royal Australian and New Zealand College of Obstetricians and Gynaecologists. Prenatal screening and diagnosis of chromosomal and genetic conditions in the fetus in pregnancy; 2015.

Vanakker O, Vilain C, Janssens K, et al. Implementation of genomic arrays in prenatal diagnosis: the Belgian approach to meet the challenges. Eur J Med Genet 2014;57:151-6.

de Wit MC, et Srebniak MI, Govaerts LC, Van Opstal D, Galjaard RJ, Go AT. Additional value of prenatal genomic array testing in fetuses with isolated structural ultrasound abnormalities and a normal karyotype: a systematic review of the literature. Ultrasound Obstet Gynecol 2014;43:139-46.

Cheng SSW, Chan KYK, Leung KKP, et al. Experience of chromosomal microarray applied in prenatal and postnatal settings in Hong Kong. Am J Med Genet C Semin Med Genet 2019;181:196-207.

Hillman SC, McMullan DJ, Hall G, et al. Use of prenatal chromosomal microarray: prospective cohort study and systematic review and meta-analysis. Ultrasound Obstet Gynecol 2013;41:610-20.

Hillman SC, Pretlove S, Coomarasamy A, et al. Additional information from array comparative genomic hybridization technology over conventional karyotyping in prenatal diagnosis: a systematic review and meta-analysis. Ultrasound Obstet Gynecol 2011;37:6-14.

Brady PD, Delle Chiaie B, Christenhusz G, et al. A prospective study of the clinical utility of prenatal chromosomal microarray analysis in fetuses with ultrasound abnormalities and an exploration of a framework for reporting unclassified variants and risk factors. Genet Med 2014;16:469-76.

Lee CN, Lin SY, Lin CH, Shih JC, Lin TH, Su YN. Clinical utility of array comparative genomic hybridisation for prenatal diagnosis: a cohort study of 3171 pregnancies. BJOG 2012;119:614-25.

American College of Obstetricians and Gynecologists Committee on Genetics. Committee opinion No. 581: the use of chromosomal microarray analysis in prenatal diagnosis. Obstet Gynecol 2013;122:1374-7.

Duncan A, Langlois S; SOGC Genetics Committee; CCMG Prenatal Diagnosis Committee. Use of array genomic hybridization technology in prenatal diagnosis in Canada. J Obstet Gynaecol Can 2011;33:1256-9.

Novelli A, Grati FR, Ballarati L, et al. Microarray application in prenatal diagnosis: a position statement from the cytogenetics working group of the Italian Society of Human Genetics (SIGU), November 2011. Ultrasound Obstet Gynecol 2012;39:384-8.

Kan A. Chromosomal microarray (CMA) replacing traditional karyotyping in HA prenatal diagnosis service. Hospital Authority Convention 2019: Abstract No. HAC1305. Available at: https://haconvention2019.dryfta.com/en/abstract-archive/abstract/public/1305/chromosomalmicroarray-cma-replacing-traditional-karyotyping-in-haprenatal-diagnosis-service. Accessed 19 July 2019.

Humphrey WM, Griffin EE, Shaffer BL, Caughey AB. Microarray versus karyotype for pregnant women with anomalies found on ultrasonography. Am J Obstet Gynecol 2016;214(Suppl):S182-S183.

Robson SC, Chitty LS, Morris S, et al. Evaluation of array comparative genomic hybridisation in prenatal diagnosis of fetal anomalies: a multicentre cohort study with cost analysis and assessment of patient, health professional and commissioner preferences for array comparative genomic hybridisation. Southampton (UK): NIHR Journals Library; 2017.

Cheng HYH, Kan AS, Hui PW, Lee CP, Tang MHY. Bridging the gap from prenatal karyotyping to whole-genome array comparative genomic hybridization in Hong Kong: survey on knowledge and acceptance of health-care providers and pregnant women. Arch Gynecol Obstet 2017;296:1109-16.

Choy KW, Chan LW, Tang MH, Ng LK, Leung TY, Lau TK. Prenatal findings and delineation of de novo concurrent partial trisomy 7q(7q31.2 --> qter) and partial monosomy 6q(6q26 --> qter) by high-resolution array CGH. J Matern Fetal Neonatal Med 2009;22:1014-20.

Leung TY, Vogel I, Lau TK, et al. Identification of submicroscopic chromosomal aberrations in fetuses with increased nuchal translucency and apparently normal karyotype. Ultrasound Obstet Gynecol 2011;38:314-9.

Kan AS, Chan KY. Role of chromosomal microarray in prenatal diagnosis. Hong Kong Med Diary 2015;20:20-4.

Cao Y, Li Z, Rosenfeld JA, et al. Contribution of genomic copy-number variations in prenatal oral clefts: a multicenter cohort study. Genet Med 2016;18:1052-5.

Cheng YK, Huang J, Law KM, Chan YM, Leung TY, Choy KW. Prenatal diagnosis of maternally inherited X-linked Opitz G/BBB syndrome by chromosomal microarray in a fetus with complex congenital heart disease. Clin Chim Acta 2014;436:140-2.

Cheung KW, Lai CWS, Mak CCY, Hui PW, Chung BHY, Kan ASY. A case of prenatal isolated talipes and 22q11.2 deletion syndrome: an important chromosomal disorder missed by noninvasive prenatal screening. Prenat Diagn 2018;38:376-8.

Choy KW, To KF, Chan AW, Lau TK, Leung TY. Second-trimester detection of Mowat-Wilson syndrome using comparative genomic hybridization microarray testing. Obstet Gynecol 2010;115:462-5.

Huang J, Poon LC, Akolekar R, Choy KW, Leung TY, Nicolaides KH. Is high fetal nuchal translucency associated with submicroscopic chromosomal abnormalities on array CGH? Ultrasound Obstet Gynecol 2014;43:620-4.

Hui ASY, Au PKC, Ting YH, et al. First report of a novel deletion due to εγδβ-thalassemia in a Chinese family. Hemoglobin 2017;41:175-9.

Kong GW, Cao Y, Huang J, et al. Prenatal detection of 10q22q23 duplications: dilemmas in phenotype prediction. Prenat Diagn 2016;36:1211-6.

Lau W, Yung W, Leung W, et al. A case of “familial atretic encephalocele”. Ultrasound Obstet Gynecol 2018 [Epub ahead of print].

Law LW, Lau TK, Fung TY, Leung TY, Wang CC, Choy KW. De novo 16p13.11 microdeletion identified by high-resolution array CGH in a fetus with increased nuchal translucency. BJOG 2009;116:339-43.

Luk HM, Wong VC, Lo IF, et al. A prenatal case of split-hand malformation associated with 17p13.3 triplication: a dilemma in genetic counseling. Eur J Med Genet 2014;57:81-4.

Leung WC, Lau WL, Lo TK, et al. Two IUGR foetuses with maternal uniparental disomy of chromosome 6 or UPD(6) mat. J Obstet Gynaecol 2017;37:113-5.

Chau MHK, Cao Y, Yvonne Kwok KY, et al. Characteristics and mode of inheritance of pathogenic copy number variants in prenatal diagnosis. Am J Obstet Gynecol 2019. pii: S0002-9378(19)30771-9. [Epub ahead of print]

Kearney HM, Thorland EC, Brown KK, et al. American College of Medical Genetics standards and guidelines for interpretation and reporting of postnatal constitutional copy number variants. Genet Med 2011;13:680-5.

The Royal College of Pathologists, Joint Committee on Genomics in Medicine. Recommendations for the use of chromosome microarray in pregnancy; 2015.

Walker L, Watson CM, Hewitt S, Crinnion LA, Bonthron DT, Cohen KE. An alternative to array-based diagnostics: a prospectively recruited cohort, comparing arrayCGH to next-generation sequencing to evaluate foetal structural abnormalities. J Obstet Gynaecol 2019;39:328-34.

Dong Z, Zhang J, Hu P, et al. Low-pass whole-genome sequencing in clinical cytogenetics: a validated approach. Genet Med 2016;18:940-8.

Liang D, Wang Y, Ji X, et al. Clinical application of whole-genome low-coverage next-generation sequencing to detect and characterize balanced chromosomal translocations. Clin Genet 2017;91:605-10.

Zhou B, Ho SS, Zhang X, Pattni R, Haraksingh RR, Urban AE. Whole-genome sequencing analysis of CNV using low-coverage and paired-end strategies is efficient and outperforms array-based CNV analysis. J Med Genet 2018;55:735-43.

Qi H, Xuan ZL, Du Y, et al. High resolution global chromosomal aberrations from spontaneous miscarriages revealed by low coverage whole genome sequencing. Eur J Obstet Gynecol Reprod Biol 2018;224:21-8.

Xie C, Tammi MT. CNV-seq, a new method to detect copy number variation using high-throughput sequencing. BMC Bioinformatics 2009;10:80.

Wang J, Chen L, Zhou C, et al. Identification of copy number variations among fetuses with ultrasound soft markers using next-generation sequencing. Sci Rep 2018;8:8134.

Wang J, Chen L, Zhou C, et al. Prospective chromosome analysis of 3429 amniocentesis samples in China using copy number variation sequencing. Am J Obstet Gynecol 2018;219:287.e1-287.e18.

Wang J, Chen L, Zhou C, et al. Application of copy number variation sequencing for prenatal diagnosis in women at an advanced maternal age [in Chinese]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 2019;36:533-7.

Clinical Genetics Group Of Medical Genetics Branch Chinese Medical Association, Professional Committee For Prenatal Diagnosis Of Genetic Diseases Medical Genetics Branch Of Chinese Medical Association, Group Of Genetic Disease Prevention And Control Birth Defect Prevention And Control Committee Of Chinese Society Of Preventive Medicine. Expert consensus on the application of low-depth

whole genome sequencing in prenatal diagnosis [in Chinese]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 2019;36:293-6.

Rehm HL, Bale SJ, Bayrak-Toydemir P, et al. ACMG clinical laboratory standards for next-generation sequencing. Genet Med 2013;15:733-47.

Al-Mubarak B, Abouelhoda M, Omar A, et al. Whole exome sequencing reveals inherited and de novo variants in autism spectrum disorder: a trio study from Saudi families. Sci Rep 2017;7:5679.

Fu F, Li R1, Li Y, et al. Whole exome sequencing as a diagnostic adjunct to clinical testing in fetuses with structural abnormalities. Ultrasound Obstet Gynecol 2018;51:493-502.

Hegde M, Santani A, Mao R, Ferreira-Gonzalez A, Weck KE, Voelkerding KV. Development and validation of clinical whole-exome and whole-genome sequencing for detection of germline variants in inherited disease. Arch Pathol Lab Med 2017;141:798-805.

Leung GKC, Luk HM, Tang VHM, et al. Integrating functional analysis in the next-generation sequencing diagnostic pipeline of RASopathies. Sci Rep 2018;8:2421.

Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 2015;17:405-24.

Lord J, McMullan DJ, Eberhardt RY, et al. Prenatal exome sequencing analysis in fetal structural anomalies detected by ultrasonography (PAGE): a cohort study. Lancet 2019;393:747-57.

Petrovski S, Aggarwal V, Giordano JL, et al. Whole-exome sequencing in the evaluation of fetal structural anomalies: a prospective cohort study. Lancet 2019;393:758-67.

Leung GKC, Mak CCY, Fung JLF, et al. Identifying the genetic causes for prenatally diagnosed structural congenital anomalies (SCAs) by whole-exome sequencing (WES). BMC Med Genomics 2018;11:93.

International Society for Prenatal Diagnosis; Society for Maternal and Fetal Medicine; Perinatal Quality Foundation. Joint Position Statement from the International Society for Prenatal Diagnosis (ISPD), the Society for Maternal Fetal Medicine (SMFM), and the Perinatal Quality Foundation (PQF) on the use of genome-wide sequencing for fetal diagnosis. Prenat Diagn 2018;38:6-9.

Chen W, Kalscheuer V, Tzschach A, et al. Mapping translocation breakpoints by next-generation sequencing. Genome Res 2008;18:1143-9.

Gribble SM, Ng BL, Prigmore E, Fitzgerald T, Carter NP. Array painting: a protocol for the rapid analysis of aberrant chromosomes using DNA microarrays. Nat Protoc 2009;4:1722-36.

Higgins AW, Alkuraya FS, Bosco AF, et al. Characterization of apparently balanced chromosomal rearrangements from the developmental genome anatomy project. Am J Hum Genet 2008;82:712-22.

Sobreira NL, Gnanakkan V, Walsh M, et al. Characterization of complex chromosomal rearrangements by targeted capture and next-generation sequencing. Genome Res 2011;21:1720-7.

Talkowski ME, Ernst C, Heilbut A, et al. Next-generation sequencing strategies enable routine detection of balanced chromosome rearrangements for clinical diagnostics and genetic research. Am J Hum Genet 2011;88:469-81.

Talkowski ME, Ordulu Z, Pillalamarri V, et al. Clinical diagnosis by whole-genome sequencing of a prenatal sample. N Engl J Med 2012;367:2226-32.

Vergult S, Van Binsbergen E, Sante T, et al. Mate pair sequencing for the detection of chromosomal aberrations in patients with intellectual disability and congenital malformations. Eur J Hum Genet 2014;22:652-9.

Chow JFC, Cheng HHY, Lau EYL, Yeung WSB, Ng EHY. Distinguishing between carrier and non-carrier embryos with the use of long-read sequencing in preimplantation genetic testing for reciprocal translocations. Genomics 2019. pii:S0888-7543(18)30617-7. [Epub ahead of print]

Escaramis G, Docampo E, Rabionet R. A decade of structural variants: description, history and methods to detect structural variation. Brief Funct Genomics 2015;14:305-14.

Ameur A, Kloosterman WP, Hestand MS. Single-molecule sequencing: towards clinical applications. Trends Biotechnol 2019;37:72-85.

van Dijk EL, Jaszczyszyn Y, Naquin D, Thermes C. The third revolution in sequencing technology. Trends Genet 2018;34:666-81.

Ardui S, Race V, de Ravel T, et al. Detecting AGG interruptions in females with a FMR1 premutation by long-read single-molecule sequencing: a 1 year clinical experience. Front Genet 2018;9:150.

Ardui S, Race V, Zablotskaya A, et al. Detecting AGG interruptions in male and female FMR1 premutation carriers by single-molecule sequencing. Hum Mutat 2017;38:324-31.

Mao Q, Chin R, Xie W, et al. Advanced whole-genome sequencing and analysis of fetal genomes from amniotic fluid. Clin Chem 2018;64:715-25.